Clinicians at the BSA Hospital in Amarillo, Texas, are using wearables from Denver-based BioIntelliSense for continuous patient monitoring.

The hospital owned by Ardent Health Services launched the continuous patient monitoring initiative to empower clinicians with greater data-driven insights for patient care and to optimise clinical and operational workflow.

It began using the BioButton wearable device and BioCloud analytics engine in September to automate the collection of inpatient vital signs in general care units and increase patient and clinician satisfaction.

With plans for expansion across Ardent’s 30 hospitals, the programme also leverages BioIntelliSense’s FDA-cleared AlertWatch clinical intelligence and triage option. The integrated dashboard and intuitive display provide clinicians with a central view of high-frequency patient trending data and algorithmic-based alerting that supports earlier intervention.

As part of the inpatient continuous monitoring initiative, patients wear the BioButton throughout their stay. The patient-friendly device captures and wirelessly transmits up to 1440 sets of vital sign measurements per day at a fraction of the cost of traditional, manually collected vital sign measurements, which are typically only collected four to six times per day.

This enables clinicians to identify stable patients who may be candidates for early discharge, potentially reducing hospital stays while providing medical grade monitoring in a patient’s home.

“This partnership is another step forward in our efforts to leverage game-changing clinical technology to transform the care delivered in and outside of our hospitals and clinics,” said Ardent chief executive officer Marty Bonick. “These tools empower our clinical teams to work at the top of their licence while providing actionable insights that allow us to tailor care in near real time, supporting better outcomes and an improved experience for both patients and caregivers.”

BioIntelliSense’s medical-grade BioButton wearable device, along with its algorithmic-based data services, enables effortless remote data capture and continuous multi-parameter monitoring on a single device in both acute and post-acute settings.

“We are at a critical inflection point for healthcare where the technology now exists to enable a more intelligent model of care delivery that allows providers to take better care of more patients at a fraction of the cost,” said James Mault, CEO of BioIntelliSense. “We are proud to work with the committed, forward-thinking team at Ardent to deliver this next standard of continuous patient monitoring, so patients get the best care when and where they need it most and hospitals get the tools they need to enable more efficient clinical workflow given the growing workforce shortage crisis.”

In combination with BioIntelliSense’s BioCloud data analytics, patient-specific trending and clinical intelligence may allow for early detection of adverse trends and proactive interventions. The BioIntelliSense and AlertWatch are integrated with Ardent’s Epic electronic health record to streamline clinical workflow and enable a high-resolution view of a patient’s health status from in-hospital to home.

Ardent Health Services owns and operates 30 hospitals and nearly 200 sites of care in six states with more than 24,000 employees.